Local Anesthetics in Diabetic Retinopathy Procedures: A Comprehensive Review With a Focus on Lidocaine-Based Pain Control
- PMID: 40786329
- PMCID: PMC12334348
- DOI: 10.7759/cureus.87632
Local Anesthetics in Diabetic Retinopathy Procedures: A Comprehensive Review With a Focus on Lidocaine-Based Pain Control
Abstract
This review investigates commonly used local anesthetic agents and administration methods in diabetic retinopathy (DR) procedures, such as pan-retinal photocoagulation, intravitreal injections, and vitrectomy, focusing on pain control and procedural outcomes. A systematic review of PubMed was conducted to identify studies examining local anesthetic use in DR procedures. Studies were screened for relevance, full-text availability, and methodological rigor. Fourteen studies met the inclusion criteria and were evaluated for anesthetic type, dosage, application route, co-administration, and patient outcome. The Joanna Briggs Institute (JBI) critical appraisal tools were used to evaluate the methodological quality and risk of bias for each included study. Lidocaine emerged as the most frequently used anesthetic, effectively reducing pain and systolic pressure during pan-retinal photocoagulation and posterior vitrectomy. There was a statistically significant difference in the dosage of lidocaine (2.33 ± 1.00%) vs other alternative anesthetics (0.475 ± 0.05%) for surgical procedures used to treat DR. The topical application of lidocaine was preferred for its ease of administration and reduced risk of complications. Furthermore, povidone, an antiseptic agent, was frequently co-administered to disinfect the ocular surface and maintain aseptic conditions during intravitreal injections, reducing the risk of infection. Among the local anesthetics reviewed, lidocaine, administered topically or via injection, was most frequently studied and demonstrated effective procedural analgesia and favorable post-surgical outcomes. These findings suggest lidocaine is a suitable choice for DR procedures. Exploration of lidocaine's impact, consideration of patient medical history, and examination of a broader range of co-administered drugs are recommended for comprehensive insights into optimizing patient outcomes.
Keywords: anesthesia; diabetic retinopathy; lidocaine; pain management; panretinal photocoagulation; surgical outcomes.
Copyright © 2025, Rezaei et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults.Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD009642. doi: 10.1002/14651858.CD009642.pub3. Cochrane Database Syst Rev. 2018. PMID: 29864216 Free PMC article.
-
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.Health Technol Assess. 2025 May;29(23):1-16. doi: 10.3310/KRWP1264. Health Technol Assess. 2025. PMID: 40347224 Free PMC article.
-
Local anaesthesia for pain control in first trimester surgical abortion.Cochrane Database Syst Rev. 2024 Feb 13;2(2):CD006712. doi: 10.1002/14651858.CD006712.pub3. Cochrane Database Syst Rev. 2024. PMID: 38348912 Free PMC article.
-
Injectable local anaesthetic agents for dental anaesthesia.Cochrane Database Syst Rev. 2018 Jul 10;7(7):CD006487. doi: 10.1002/14651858.CD006487.pub2. Cochrane Database Syst Rev. 2018. PMID: 29990391 Free PMC article.
-
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.Health Technol Assess. 2024 Dec;29(23):1-71. doi: 10.3310/PCGV5709. Health Technol Assess. 2024. PMID: 39673354
References
-
- Of neurons and pericytes: the neuro-vascular approach to diabetic retinopathy. Eleftheriou CG, Ivanova E, Sagdullaev BT. Vis Neurosci. 2020;37:0. - PubMed
-
- The microenvironment of proliferative diabetic retinopathy supports lymphatic neovascularization. Gucciardo E, Loukovaara S, Korhonen A, et al. J Pathol. 2018;245:172–185. - PubMed
-
- Diabetic retinopathy. Shaya FT, Aljawadi M. https://pmc.ncbi.nlm.nih.gov/articles/PMC2701130/ Clin Ophthalmol. 2007;1:259–265. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous